<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04685018</url>
  </required_header>
  <id_info>
    <org_study_id>bram vervliet</org_study_id>
    <nct_id>NCT04685018</nct_id>
  </id_info>
  <brief_title>The Neurocircuitry of Relief During Avoidance Learning in Patients With Obsessive-compulsive Disorder</brief_title>
  <acronym>AvoidOCD</acronym>
  <official_title>The Neurocircuitry of Relief During Avoidance Learning in Patients With Obsessive-compulsive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>KU Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>KU Leuven</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the neuro-mechanisms underpinning persistent avoidance in OCD patients&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many compulsions displayed by obsessive-compulsive disorder (OCD) patients serve to protect&#xD;
      against perceived threat and can, therefore, be conceptualized as 'avoidance responses'.&#xD;
      Exposure treatment with response prevention (ET+RP) is aimed at exposing patients to their&#xD;
      obsessive thoughts and perceived threats while preventing engagement in compulsive avoidant&#xD;
      responses. This induces extinction of threat perception and fearful arousal and hence reduces&#xD;
      the motivation to avoid. While successful in many patients, however, as much as 40% dropout&#xD;
      during treatment or display persistent avoidance after ET+RP. There is a clear need for&#xD;
      treatment improvement for these often highly disabled patients.&#xD;
&#xD;
      Improving ET+RP outcomes requires a deeper understanding of the mechanisms that drive&#xD;
      excessive and persistent avoidance in OCD patients. Psychological theories ascribe an&#xD;
      important role to the relief that follows avoidance when the anticipated threat is&#xD;
      successfully averted. This positive feeling arguably functions as a reward to reinforce the&#xD;
      foregoing avoidance actions. Indeed, fMRI studies have found that the neurocircuitry of&#xD;
      relief overlaps with that of reward, including the ventral tegmental area, ventral striatum&#xD;
      and orbitofrontal cortex. Here, the authors will test the hypothesis that&#xD;
      excessive-persistent avoidance is linked to exaggerated activation of the relief circuitry in&#xD;
      OCD patients. For that purpose, we will acquire functional brain images of OCD patients in an&#xD;
      MRI scanner and compare to healthy participants, while they participate in a computer task&#xD;
      that is designed to model avoidance learning and relief.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 10, 2020</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 10, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Avoidance responses during the avoidance-relief task</measure>
    <time_frame>1 hour for avoidance task</time_frame>
    <description>Avoidance responses during avoidance learning and test will be recorded in terms of button press and Reaction times</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Relief during the omissions of the US</measure>
    <time_frame>1 hour to perform the avoidance task</time_frame>
    <description>Relief will be measured as:&#xD;
Brain data during fMRI: whole-brain activations, as well as activations in specific regions of interest (ROI: VTA, NAcc, OFC) at the moment of the omissions of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task;&#xD;
Individual ratings: relief pleasantness ratings measured on a Likert scale from 0 (neutral) to 3 (very pleasant) after each omission of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task;&#xD;
Physiological data: skin conductance responses (SCR) at the moment of the omissions of the electrical stimulation (US) during both the avoidance learning and the extinction learning phase of the avoidance-relief task.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerance to stress</measure>
    <time_frame>1 hour to perform the avoidance task</time_frame>
    <description>The individual level of tolerance to distress will be measured via the self-administration of the Distress Tolerance Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Therapeutic outcome in OCD</measure>
    <time_frame>1 hour to perform the avoidance task</time_frame>
    <description>The therapeutic outcome in OCD individuals will be evaluated by using the Y-BOCS (self-administered) questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Resting-state connectivity</measure>
    <time_frame>1 hour to perform the avoidance task</time_frame>
    <description>The strength of connectivity between NAcc, VTA, and OFC, will be measured during the resting state MRI acquisition</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Obsessive-Compulsive Disorder</condition>
  <arm_group>
    <arm_group_label>HC</arm_group_label>
    <description>Mentally and medically healthy adults between 18 and 60 years, free from any current or previous medical or psychiatric condition.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OCD</arm_group_label>
    <description>Adults between 18 and 60 years, with a diagnosis of Obsessive-Compulsive Disorder and medication-free or with stable medication regimen for at least 3 weeks prior to the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI acquisition</intervention_name>
    <description>Participants from the two groups will perform an avoidance-relief task inside an MRI scanner</description>
    <arm_group_label>HC</arm_group_label>
    <arm_group_label>OCD</arm_group_label>
    <other_name>Behavioral task</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy group: Mentally and medically healthy adults between 18 and 60 years, free from any&#xD;
        current or previous medical or psychiatric condition.&#xD;
&#xD;
        OCD group: Same as the healthy group, except for the diagnosis of OCD and medication-free&#xD;
        or with a stable medication regimen for at least 3 weeks prior to the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers 18-60 years old;&#xD;
&#xD;
          -  Participants are motivated and give written informed consent;&#xD;
&#xD;
          -  Adequate demand of Dutch language;&#xD;
&#xD;
          -  Subjects have never participated in a fear conditioning task;&#xD;
&#xD;
          -  Diagnosis of OCD (for OCD group only);&#xD;
&#xD;
          -  Contraindications for the MRI exam.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Current neurological (e.g. Epilepsia), respiratory, cardiovascular, metabolic,&#xD;
             gastrointestinal, endocrine (especially diabetes), renal or urinary diseases,&#xD;
             psychiatric disorder or other relevant medical histories (except for OCD in the OCD&#xD;
             group);&#xD;
&#xD;
          -  Being pregnant or lactating;&#xD;
&#xD;
          -  Alcohol intake greater than 14 alcoholic units per week (one alcoholic unit = 10 gr&#xD;
             ethanol);&#xD;
&#xD;
          -  History of cannabis use or any other drug of abuse during the 3 months prior to the&#xD;
             study;&#xD;
&#xD;
          -  The medical doctor has asked to the participant to stay away from stressful&#xD;
             situations;&#xD;
&#xD;
          -  Electronic implants (e.g., pacemaker);&#xD;
&#xD;
          -  Pain or other condition of the hand or the wrist.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bram Vervliet, Prof. Dr.</last_name>
    <phone>+32 16 3 26 145</phone>
    <email>bram.vervliet@kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chris Bervoets, Prof. Dr.</last_name>
    <phone>+32 16 34 08 77</phone>
    <email>chris.bervoets@kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Psychiatry | UZ Leuven campus Gasthuisberg</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bram Vervliet, Prof. Dr.</last_name>
      <phone>+32 16 3 26145</phone>
      <email>bram.vervliet@kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Chris Bervoets, Prof. Dr.</last_name>
      <email>chris.bervoets@upckuleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Bram Vervliet</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chris Bervoets</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <results_reference>
    <citation>Vervliet B, Lange I, Milad MR. Temporal dynamics of relief in avoidance conditioning and fear extinction: Experimental validation and clinical relevance. Behav Res Ther. 2017 Sep;96:66-78. doi: 10.1016/j.brat.2017.04.011. Epub 2017 Apr 23.</citation>
    <PMID>28457484</PMID>
  </results_reference>
  <results_reference>
    <citation>Milad MR, Furtak SC, Greenberg JL, Keshaviah A, Im JJ, Falkenstein MJ, Jenike M, Rauch SL, Wilhelm S. Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit. JAMA Psychiatry. 2013 Jun;70(6):608-18; quiz 554. doi: 10.1001/jamapsychiatry.2013.914.</citation>
    <PMID>23740049</PMID>
  </results_reference>
  <results_reference>
    <citation>Leknes S, Lee M, Berna C, Andersson J, Tracey I. Relief as a reward: hedonic and neural responses to safety from pain. PLoS One. 2011 Apr 7;6(4):e17870. doi: 10.1371/journal.pone.0017870.</citation>
    <PMID>21490964</PMID>
  </results_reference>
  <results_reference>
    <citation>Gillan CM, Morein-Zamir S, Urcelay GP, Sule A, Voon V, Apergis-Schoute AM, Fineberg NA, Sahakian BJ, Robbins TW. Enhanced avoidance habits in obsessive-compulsive disorder. Biol Psychiatry. 2014 Apr 15;75(8):631-8. doi: 10.1016/j.biopsych.2013.02.002. Epub 2013 Mar 16.</citation>
    <PMID>23510580</PMID>
  </results_reference>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>December 14, 2020</study_first_submitted>
  <study_first_submitted_qc>December 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 28, 2020</study_first_posted>
  <last_update_submitted>December 21, 2020</last_update_submitted>
  <last_update_submitted_qc>December 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>KU Leuven</investigator_affiliation>
    <investigator_full_name>Bram Vervliet</investigator_full_name>
    <investigator_title>Principal Investigator Prof. Dr. Bram Vervliet</investigator_title>
  </responsible_party>
  <keyword>Avoidance behavior</keyword>
  <keyword>Reward</keyword>
  <keyword>Conditioning</keyword>
  <keyword>Extinction</keyword>
  <keyword>Anxiety Disorders</keyword>
  <keyword>OCD</keyword>
  <keyword>fMRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

